XML 63 R51.htm IDEA: XBRL DOCUMENT v3.19.1
STOCK OPTIONS AND AWARDS (Details)
12 Months Ended
Dec. 29, 2018
USD ($)
Plan
$ / shares
shares
Dec. 30, 2017
USD ($)
$ / shares
shares
Stock Options [Abstract]    
Number of plans that have shares reserved for further issuance | Plan 1  
Expected term 3 years 6 months 3 years 6 months
Volatility deviation 29.50% 22.60%
Risk free rate 2.33% 1.47%
Minimum [Member]    
Stock Options [Abstract]    
Percentage of fair market value of stock on grant date for exercise price 100.00%  
Stock Appreciation Rights (SARs) [Member]    
Stock Options [Abstract]    
Stock-based compensation expense | $ $ 276,778 $ 172,806
Number of Units, Stock Appreciation Rights (SARs) [Roll Forward]    
Outstanding at beginning of period (in shares) | shares 141,500 0
Issued (in shares) | shares 51,000 149,500
Forfeited (in shares) | shares (3,333) (8,000)
Outstanding at end of period (in shares) | shares 189,167 141,500
Weighted - Average Exercise Price, Stock Appreciation Rights (SARs) [Abstract]    
Outstanding at beginning of period (in dollars per share) $ 20.36 $ 0
Issued (in dollars per share) 24.90 20.39
Forfeited (in dollars per share) 19.10 21.10
Outstanding at end of period (in dollars per share) 21.46 $ 20.36
SARs Grants Outstanding and Exercisable [Abstract]    
Minimum Range of Exercise Prices (in dollars per share) 19.10  
Maximum Range of Exercise Prices (in dollars per share) $ 24.90  
Outstanding (in shares) | shares 189,167  
Weighted- Average Remaining Contractual Life 3 years 6 months  
Weighted- Average Exercise Price (in dollars per share) $ 21.46  
Exercisable as of December 29, 2018 (in shares) | shares 19,670  
Exercisable, Weighted- Average Remaining Contractual Life 3 years 3 months 18 days  
Exercisable, Weighted- Average Exercise Price (in dollars per share) $ 19.10  
Stock Options [Member]    
Number of Units, Stock Appreciation Rights (SARs) [Roll Forward]    
Outstanding at beginning of period (in shares) | shares 25,000 0
Issued (in shares) | shares 0 25,000
Forfeited (in shares) | shares 0 0
Outstanding at end of period (in shares) | shares 25,000 25,000
Weighted - Average Exercise Price, Stock Appreciation Rights (SARs) [Abstract]    
Outstanding at beginning of period (in dollars per share) $ 0 $ 0
Issued (in dollars per share) 0 0
Forfeited (in dollars per share) 0 0
Outstanding at end of period (in dollars per share) 0 $ 0
SARs Grants Outstanding and Exercisable [Abstract]    
Maximum Range of Exercise Prices (in dollars per share) $ 0  
Outstanding (in shares) | shares 25,000  
Weighted- Average Remaining Contractual Life 3 years 3 months 18 days  
Weighted- Average Exercise Price (in dollars per share) $ 0  
Exercisable as of December 29, 2018 (in shares) | shares 0  
Exercisable, Weighted- Average Remaining Contractual Life 0 years  
Exercisable, Weighted- Average Exercise Price (in dollars per share) $ 0  
Restricted Stock [Member]    
Stock Options [Abstract]    
Issued (in shares) | shares 0  
Stock Options and SARs [Member]    
SARs Grants Outstanding and Exercisable [Abstract]    
Outstanding options, intrinsic value | $ $ 1,104,410  
2010 Plan [Member]    
Stock Options [Abstract]    
Shares available for future grant (in shares) | shares 274,500